Intravenous tissue-type plasminogen activator therapy is an independent risk factor for symptomatic intracerebral hemorrhage after carotid Endarterectomy

Ananth K. Vellimana, Chester K. Yarbrough, Spiros Blackburn, Russell G. Strom, Thomas K. Pilgram, Jin Moo Lee, Robert L. Grubb, Keith M. Rich, Michael R. Chicoine, Ralph G. Dacey, Colin P. Derdeyn, Gregory J. Zipfel

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

Carotid endarterectomy (CEA) for symptomatic carotid artery stenosis and intravenous tissue-type plasminogen activator (IV-tPA) for acute ischemic stroke are proven therapies; however, the safety of CEA in stroke patients who recently received IV-tPA has not been established. OBJECTIVE:: To evaluate the safety of CEA in stroke patients who recently received IV-tPA. METHODS:: A retrospective review of patients who underwent CEA for symptomatic carotid artery stenosis was performed. The primary end point was postoperative symptomatic intracerebral hemorrhage (sICH). A univariate analysis of potential risk factors for sICH, including IV-tPA therapy, timing of CEA, degree of stenosis, and stroke severity, was performed. Factors with a value of P < .1 on univariate analysis were tested further. RESULTS:: Among 142 patients, 3 suffered sICH after CEA: 2 of 11 patients treated with IV-tPA (18.2%) and 1 of 131 patients not treated with IV-tPA (0.8%). Both IV-tPA patients suffering sICH underwent CEA within 3 days of tPA administration. On univariate analysis, IV-tPA (P = .02), female sex (P = .09), shorter time between ischemic event and CEA (P = .06), and lower mean arterial pressure during the first 48 hours of admission (P = .08) were identified as risk factors for sICH. On multivariate analysis, IV-tPA was the only significant risk factor (P = .002 by stepwise logistic regression; P = .03 by nominal logistic regression). CONCLUSION:: This study indicates that IV-tPA is an independent risk factor for sICH after CEA. This suggests that CEA should be pursued cautiously in patients who recently received IV-tPA. Early surgery may be associated with an increased risk for sICH. ABBREVIATIONS:: CEA, carotid endarterectomyIV-tPA, intravenous recombinant tissue-type plasminogen activatorMAP, mean arterial pressureNASCET, North American Symptomatic Carotid Endarterectomy TrialNIHSS, National Institutes of Health Stroke ScaleNINDS, National Institute of Neurological Disorders and StrokesICH, symptomatic intracerebral hemorrhageTIA, transient ischemic attack

Original languageEnglish
Pages (from-to)254-260
Number of pages7
JournalNeurosurgery
Volume74
Issue number3
DOIs
StatePublished - Mar 1 2014

Keywords

  • Carotid endarterectomy
  • Intracerebral hemorrhage
  • Thrombolysis
  • Tissue plasminogen activator

Fingerprint Dive into the research topics of 'Intravenous tissue-type plasminogen activator therapy is an independent risk factor for symptomatic intracerebral hemorrhage after carotid Endarterectomy'. Together they form a unique fingerprint.

  • Cite this